Glitazones accelerate bone loss and increase the risk of fracture in patients with type 2 diabetes mellitus

Author:  

Publisher: Adis International

ISSN: 1172-0360

Source: Drugs & Therapy Perspectives, Vol.26, Iss.1, 2010-01, pp. : 22-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract